Increasing Copays for Brand Medicines Used by Low-Income Beneficiaries May Compromise Access to Care, Harm Patient Outcomes, and Raise Overall Medicare Costs - Prescription costs - Document - PDFSEARCH.IO

First Page	Meta Content
	Increasing Copays for Brand Medicines Used by Low-Income Beneficiaries May Compromise Access to Care, Harm Patient Outcomes, and Raise Overall Medicare Costs Add to Reading List Document Date: 2014-01-28 14:35:13 Open Document File Size: 199,28 KB Share Result on Facebook Country United States / / Currency USD / / Facility LE Garrison / IMS Institute / / IndustryTerm health services / generic products / / MedicalCondition greater disease / hypertension / Cancer / HIV / low-income cancer / hyperlipidemia / high cholesterol / patient illness / dyslipidemia drugs / Therapeutic Area Hypertension / osteoporosis / HIV/AIDS / Epilepsy / depression / common diseases / chronic conditions / / Organization Congress / FDA / Medicare Payment Advisory Commission / HIV / IMS Institute for Healthcare Informatics / Congressional Budget Office / Kaiser Family Foundation / LIS Medicare / Medicare / / Person Mehmet Oz / / Position Governor / President / physician / General / / URL http / SocialTag Medicine Medicare Part D Medicare Copayment Medicaid Generic drug Out-of-pocket expenses Prescription medication Formulary Pharmaceuticals policy

Increasing Copays for Brand Medicines Used by Low-Income Beneficiaries May Compromise Access to Care, Harm Patient Outcomes, and Raise Overall Medicare CostsAdd to Reading List